tiprankstipranks
Trending News
More News >
BB Biotech AG (CH:BION)
:BION

Compare BB Biotech (BION) vs. Competitors

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BB Biotech
CHF45.40
CHF2.49B
31.02%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF145.75M
-2.50
1.40%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF634.73M
16.63
8.43%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.15
CHF791.95M
-8.17
195.50%
2 Buy
0 Hold
0 Sell
Moderate Buy
Kuros Biosciences
CHF28.16
CHF916.80M
498.59
20.25%
1 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF14.60
$303.08M
-487.07
71.56%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:BION
BB Biotech
45.40
12.95
39.91%
CH:MOLN
Molecular Partners AG
3.61
0.37
11.42%
CH:BSLN
Basilea Pharmaceutica
52.10
5.10
10.85%
CH:IDIA
Idorsia Ltd
3.15
2.06
187.93%
CH:KURN
Kuros Biosciences
23.40
4.70
25.13%
CH:NWRN
Newron Pharmaceuticals SpA
14.60
6.24
74.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts